CSRNP1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	19 studies	32% ± 12%	Explore
natural killer cell	18 studies	25% ± 11%	Explore
fibroblast	17 studies	30% ± 12%	Explore
conventional dendritic cell	15 studies	33% ± 14%	Explore
CD4-positive, alpha-beta T cell	15 studies	28% ± 8%	Explore
smooth muscle cell	14 studies	31% ± 12%	Explore
classical monocyte	13 studies	28% ± 7%	Explore
macrophage	13 studies	24% ± 8%	Explore
T cell	12 studies	31% ± 11%	Explore
mast cell	12 studies	26% ± 8%	Explore
regulatory T cell	12 studies	29% ± 12%	Explore
non-classical monocyte	11 studies	30% ± 10%	Explore
CD8-positive, alpha-beta T cell	11 studies	24% ± 6%	Explore
B cell	11 studies	22% ± 5%	Explore
gamma-delta T cell	11 studies	29% ± 16%	Explore
pericyte	10 studies	43% ± 17%	Explore
memory B cell	10 studies	27% ± 10%	Explore
endothelial cell of vascular tree	10 studies	35% ± 16%	Explore
monocyte	8 studies	26% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	35% ± 18%	Explore
naive B cell	8 studies	27% ± 10%	Explore
endothelial cell of artery	8 studies	35% ± 17%	Explore
capillary endothelial cell	7 studies	35% ± 15%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	30% ± 12%	Explore
dendritic cell	7 studies	33% ± 10%	Explore
mucosal invariant T cell	7 studies	38% ± 19%	Explore
plasmacytoid dendritic cell	7 studies	26% ± 12%	Explore
myeloid cell	7 studies	27% ± 11%	Explore
connective tissue cell	6 studies	24% ± 7%	Explore
myofibroblast cell	6 studies	32% ± 17%	Explore
T follicular helper cell	6 studies	33% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	35% ± 14%	Explore
type I pneumocyte	5 studies	24% ± 8%	Explore
mononuclear phagocyte	5 studies	20% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	26% ± 6%	Explore
pro-B cell	5 studies	31% ± 6%	Explore
vein endothelial cell	5 studies	28% ± 12%	Explore
mature NK T cell	5 studies	25% ± 2%	Explore
endothelial cell of lymphatic vessel	4 studies	28% ± 4%	Explore
neutrophil	4 studies	24% ± 7%	Explore
glomerular endothelial cell	4 studies	45% ± 10%	Explore
precursor B cell	4 studies	25% ± 7%	Explore
epithelial cell	4 studies	36% ± 26%	Explore
immature B cell	4 studies	24% ± 2%	Explore
basal cell	4 studies	22% ± 3%	Explore
innate lymphoid cell	4 studies	32% ± 9%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	34% ± 14%	Explore
squamous epithelial cell	3 studies	32% ± 13%	Explore
plasmablast	3 studies	26% ± 5%	Explore
abnormal cell	3 studies	34% ± 7%	Explore
type II pneumocyte	3 studies	23% ± 2%	Explore
ciliated cell	3 studies	37% ± 22%	Explore
intermediate monocyte	3 studies	35% ± 5%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	28% ± 6%	Explore
leukocyte	3 studies	28% ± 8%	Explore
group 3 innate lymphoid cell	3 studies	45% ± 17%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	34% ± 9%	Explore
secretory cell	3 studies	22% ± 6%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	8 studies	25% ± 8%	Explore
lung	5 studies	23% ± 4%	Explore
uterus	4 studies	32% ± 4%	Explore
breast	4 studies	25% ± 3%	Explore
intestine	3 studies	23% ± 10%	Explore
kidney	3 studies	21% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
prostate	100%	4962.13	244 / 245	100%	86.38	502 / 502
thymus	99%	4878.83	645 / 653	100%	69.60	603 / 605
breast	100%	7943.42	459 / 459	98%	45.70	1099 / 1118
lung	100%	12172.96	577 / 578	97%	39.48	1124 / 1155
bladder	100%	4307.33	21 / 21	96%	36.56	485 / 504
esophagus	97%	4432.17	1404 / 1445	98%	39.44	180 / 183
uterus	99%	4584.54	168 / 170	96%	36.95	442 / 459
kidney	98%	3326.94	87 / 89	96%	52.04	868 / 901
stomach	94%	5573.06	337 / 359	100%	37.34	285 / 286
ovary	96%	5742.01	172 / 180	98%	36.84	421 / 430
intestine	94%	4451.18	909 / 966	98%	36.53	518 / 527
adrenal gland	86%	3860.68	222 / 258	97%	56.67	223 / 230
liver	85%	5002.38	193 / 226	92%	25.10	373 / 406
pancreas	74%	2039.55	243 / 328	99%	56.78	176 / 178
skin	77%	5128.13	1394 / 1809	90%	22.79	424 / 472
brain	49%	1101.73	1302 / 2642	100%	59.93	702 / 705
tonsil	0%	0	0 / 0	100%	29.84	45 / 45
ureter	0%	0	0 / 0	100%	16.75	1 / 1
blood vessel	100%	7432.47	1333 / 1335	0%	0	0 / 0
adipose	100%	9375.68	1200 / 1204	0%	0	0 / 0
spleen	100%	3005.24	240 / 241	0%	0	0 / 0
peripheral blood	99%	11363.21	916 / 929	0%	0	0 / 0
muscle	94%	3043.59	758 / 803	0%	0	0 / 0
lymph node	0%	0	0 / 0	93%	24.95	27 / 29
heart	89%	4086.73	765 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	26%	2.90	21 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0048008	Biological process	platelet-derived growth factor receptor signaling pathway
GO_0006915	Biological process	apoptotic process
GO_0060021	Biological process	roof of mouth development
GO_0009791	Biological process	post-embryonic development
GO_0060325	Biological process	face morphogenesis
GO_0048705	Biological process	skeletal system morphogenesis
GO_0045944	Biological process	positive regulation of transcription by RNA polymerase II
GO_0006357	Biological process	regulation of transcription by RNA polymerase II
GO_0000785	Cellular component	chromatin
GO_0005634	Cellular component	nucleus
GO_0001228	Molecular function	DNA-binding transcription activator activity, RNA polymerase II-specific
GO_0003700	Molecular function	DNA-binding transcription factor activity
GO_0005515	Molecular function	protein binding
GO_0000981	Molecular function	DNA-binding transcription factor activity, RNA polymerase II-specific
GO_0043565	Molecular function	sequence-specific DNA binding
GO_0003674	Molecular function	molecular_function

IV. Literature review

[source]

Gene name	CSRNP1
Protein name	Alternative protein CSRNP1 Cysteine/serine-rich nuclear protein 1 (CSRNP-1) (Axin-1 up-regulated gene 1 protein) (Protein URAX1) (TGF-beta-induced apoptosis protein 3) (TAIP-3)
Synonyms	TAIP3 AXUD1
Description	FUNCTION: Binds to the consensus sequence 5'-AGAGTG-3' and has transcriptional activator activity (By similarity). May have a tumor-suppressor function. May play a role in apoptosis. .
Accessions	L8E921 ENST00000514182.1 ENST00000273153.10 Q96S65

CSRNP1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review